Millen, White, Zelano & Branigan, PC
Pyridone and aza-pyridone compounds and methods of use
Pyridone and aza-pyridone compounds of Formula I are provided, including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
GILEAD CONNECTICUT, INC. GENENTECH INC.
C A A A A A A A C A A A A A A A A A A A A A A A A C A C A C A A A A A A A A C C C A A
C07D A61P A61P A61K A61P A61K A61P A61P C07D A61P A61P A61K A61P A61P A61K A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P C07D A61K C07D A61P C07D A61P A61K A61K A61K A61P A61P A61K A61K C07F C07D C07C A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Peter A. Jianjun Antonio J. M. Jeffrey E. Aaron C. Ravi Honglu Seung H. Wendy Scott A. Daniel Xiaojing Zhongdong Pavel E. Kevin S.
Blomgren Xu Barbosa Kropf Schmitt Krishnamoorthy Zhang Lee Young Mitchell Ortwine Wang Zhao Zhichkin Currie